Subsequently, we conducted in vitro experiments using the human breast cancer cell lines MDA-MB-231 and MCF-7, in which SDC3 downregulation was achieved by a single siRNA-sequence, and a pool of 30 sequences against SDC3. Here, SDC3 is linked to breast carcinoma.